-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Lomond Therapeutics Holdings, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q4 2021 to Q3 2025.
- Lomond Therapeutics Holdings, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$8.03M, a 74% decline year-over-year.
- Lomond Therapeutics Holdings, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$30.6M, a 74.1% decline year-over-year.
- Lomond Therapeutics Holdings, Inc. annual Operating Income (Loss) for 2024 was -$16.3M, a 67% decline from 2023.
- Lomond Therapeutics Holdings, Inc. annual Operating Income (Loss) for 2023 was -$9.75M, a 19851% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)